AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
24/07/2025 – AB Science today announced that the confirmatory Phase 3 study with masitinib in amyotrophic lateral sclerosis has been authorized by the first set of European countries